What's new

Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive

Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive

Feb 20, 2025 - 15:02
 0
Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive
Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment of non-traumatic osteonecrosis, 16/01/2025 Positive
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, D...

Next Article

Orphan designation: Elraglusib Treatment of soft tissue sarcoma, 16/01/2025 Posi...

Related Posts

EMEA-002755-PIP01-19-M02

EMEA-002755-PIP01-19-M02

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Ulunar Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 23/04/2014, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 17, 2025  0

Human medicines European public assessment report (EPAR): Micardis, telmisartan, Date of authorisation: 16/12/1998, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 26, 2025  0